| |
| |
|
| Insider
Information: |
Mva Investors, Llc |
| Relationship: |
10% Owner |
| City: |
Del Mar |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
15,607,132 |
|
|
Indirect Shares
|
1,198,622 |
|
|
| Direct
Value |
$55,909,160 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
16,805,754 |
|
|
| Total
Value |
$55,909,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Somaxon Pharmaceuticals, Inc. |
SOMX |
|
2009-07-08 |
1,776,595 |
|
0 |
Premium* |
|
|
Sophiris Bio Inc. |
SPHS |
10% Owner |
2014-12-15 |
161,447 |
2014-12-15 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
2019-07-11 |
253,338 |
2015-01-29 |
0 |
Premium* |
|
|
Carisma Therapeutics Inc |
CARM |
10% Owner |
2016-06-13 |
297,860 |
|
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
10% Owner |
2019-03-04 |
3,964,970 |
|
0 |
Premium* |
|
|
Pandion Therapeutics, Inc. |
PAND |
10% Owner |
2020-07-21 |
2,107,513 |
2020-07-21 |
23,622 |
Premium* |
|
|
Iteos Therapeutics, Inc. |
ITOS |
10% Owner |
2020-07-28 |
72,243 |
2020-07-28 |
0 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
Director, 10% Owner |
2021-04-23 |
0 |
2021-04-27 |
1,175,000 |
Premium* |
|
|
Tango Therapeutics Ord Shs |
TNGX |
10% Owner |
2021-08-10 |
6,973,166 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNGX |
Tango Therapeutics Ord Sh... |
10% Owner |
– – • |
2021-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,973,166 |
|
- |
|
| RAIN |
Rain Therapeutics Inc. |
Director |
– • • |
2021-04-27 |
4 |
B |
$17.00 |
$17,425,000 |
I/I |
1,025,000 |
1,175,000 |
2.25 |
- |
|
| RAIN |
Rain Therapeutics Inc. |
Director |
– • • |
2021-04-23 |
4 |
B |
$15.58 |
$2,423,250 |
I/I |
150,000 |
150,000 |
2.25 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
B |
$19.00 |
$27,075,000 |
D/D |
1,425,000 |
72,243 |
2.45 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,992,259 |
48,691 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,385,291 |
1,385,291 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
23,622 |
23,622 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
10% Owner |
– – • |
2020-07-21 |
4 |
B |
$18.00 |
$12,999,996 |
D/D |
722,222 |
2,107,513 |
2.45 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-07-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,547) |
253,338 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(48,169) |
258,885 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(180,926) |
307,054 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
10% Owner |
– – • |
2019-03-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,964,970 |
|
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-02-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,695) |
487,980 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-02-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,955) |
494,675 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2017-10-03 |
4 |
OE |
$7.86 |
$2,106,213 |
D/D |
267,966 |
513,630 |
0 |
- |
|
| CARM |
Carisma Therapeutics Inc |
10% Owner |
– – • |
2016-06-13 |
4 |
S |
$2.74 |
$2,859,352 |
D/D |
(1,042,000) |
297,860 |
0 |
- |
|
| CARM |
Carisma Therapeutics Inc |
10% Owner |
– – • |
2016-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,730,572 |
|
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2016-01-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(522,500) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2015-09-16 |
4 |
B |
$45.00 |
$2,025,000 |
D/D |
45,000 |
522,500 |
2.45 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2015-01-29 |
4 |
B |
$20.00 |
$11,000,000 |
D/D |
550,000 |
500,000 |
2.45 |
- |
|
| SPHS |
Sophiris Bio Inc. |
10% Owner |
– – • |
2014-12-15 |
4 |
S |
$0.61 |
$537,702 |
D/D |
(881,479) |
161,447 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
|
– – – |
2009-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,776,595 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
